Dr. Mike Myers has spent 28 years in the industry contributing to the discovery and development of new drugs. He has led drug discovery teams in the pursuit of innovative treatments for cancer, CNS, Infectious and cardiovascular diseases. Across these areas of significant need, Dr. Myers has contributed as an inventor on more than 35 patents. Dr. Myers has also led efforts in evaluating new lead generation technologies, predictive ADMET and computational chemistry approaches and led a significant effort at Lilly to optimize Lead generation processes in early drug discovery. Dr. Myers has also held responsibilities as Sr. Director of Project Management at Lilly and was engaged in project and portfolio management across Discovery and Development. Currently, Mike’s main responsibilities include leading Lilly Research Laboratories Due Diligence activities supporting all in-license/acquisition, out-license and strategic partnering activities.